Cargando…
Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges
Type 1 diabetes mellitus (T1D) is a chronic disease characterized by an autoimmune destruction of insulin-producing β-pancreatic cells. Although many advances have been achieved in T1D treatment, current therapy strategies are often unable to maintain perfect control of glycemic levels. Several stud...
Autores principales: | Silva, Isaura Beatriz Borges, Kimura, Camila Harumi, Colantoni, Vitor Prado, Sogayar, Mari Cleide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284809/ https://www.ncbi.nlm.nih.gov/pubmed/35840987 http://dx.doi.org/10.1186/s13287-022-02977-y |
Ejemplares similares
-
Correction: Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges
por: Silva, Isaura Beatriz Borges, et al.
Publicado: (2022) -
Challenges in IPC training for non–healthcare workers
por: Abdul Majid, Faridah Binte, et al.
Publicado: (2022) -
IPC – Isoelectric Point Calculator
por: Kozlowski, Lukasz P.
Publicado: (2016) -
Measuring interdisciplinarity in clinical practice with IPC59, a modified and improved version of IPC65
por: Poder, Thomas G., et al.
Publicado: (2018) -
Expression and in vitro assessment of tumorigenicity for NOD1 and NOD2 receptors in breast cancer cell lines
por: Velloso, Fernando J., et al.
Publicado: (2018)